Celldex Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $18M | 463k | 39.66 |
| 2023-09-30 | $11M | 412k | 27.52 |
| 2023-06-30 | $15M | 443k | 33.93 |
| 2023-03-31 | $13M | 360k | 35.98 |
| 2022-12-31 | $20M | 450k | 44.57 |
| 2022-06-30 | $12M | 440k | 26.96 |
| 2022-03-31 | $10M | 303k | 34.06 |
| 2021-12-31 | $9.8M | 254k | 38.64 |
| 2021-09-30 | $17M | 308k | 53.99 |
| 2021-03-31 | $9.7M | 469k | 20.60 |
| 2020-12-31 | $11M | 642k | 17.52 |
| 2020-09-30 | $1.5M | 103k | 14.83 |